James Patrick Kelly - 16 Aug 2023 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role
EVP, CFO and Treasurer
Signature
/s/ John A. Herrmann III, Attorney-in-Fact
Issuer symbol
NVAX
Transactions as of
16 Aug 2023
Net transactions value
-$8,150
Form type
4
Filing time
18 Aug 2023, 16:37:36 UTC
Previous filing
14 Mar 2023
Next filing
11 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVAX Common Stock Options Exercise +2,366 +70% 5,727 16 Aug 2023 Direct F1
transaction NVAX Common Stock Tax liability $8,150 -1,143 -20% $7.13 4,584 16 Aug 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVAX Restricted Stock Units Options Exercise $0 -2,366 -50% $0.000000 2,367 16 Aug 2023 Common Stock 2,366 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
F2 The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the August 16, 2021 grant date, in each case subject to continued employment through such vesting date.